JP5106739B2 - 化粧品組成物および方法 - Google Patents

化粧品組成物および方法 Download PDF

Info

Publication number
JP5106739B2
JP5106739B2 JP2002524467A JP2002524467A JP5106739B2 JP 5106739 B2 JP5106739 B2 JP 5106739B2 JP 2002524467 A JP2002524467 A JP 2002524467A JP 2002524467 A JP2002524467 A JP 2002524467A JP 5106739 B2 JP5106739 B2 JP 5106739B2
Authority
JP
Japan
Prior art keywords
skin
wrinkles
composition
mmpi
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2002524467A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004508317A (ja
JP2004508317A5 (enExample
Inventor
デビッド エス． ラーナー
グレゴリー シュルツ
Original Assignee
クイック−メッド テクノロジーズ、インク．
ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by クイック−メッド テクノロジーズ、インク．, ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド filed Critical クイック−メッド テクノロジーズ、インク．
Publication of JP2004508317A publication Critical patent/JP2004508317A/ja
Publication of JP2004508317A5 publication Critical patent/JP2004508317A5/ja
Application granted granted Critical
Publication of JP5106739B2 publication Critical patent/JP5106739B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
JP2002524467A 2000-06-29 2001-06-29 化粧品組成物および方法 Expired - Fee Related JP5106739B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21508700P 2000-06-29 2000-06-29
US60/215,087 2000-06-29
PCT/US2001/020945 WO2002019982A2 (en) 2000-06-29 2001-06-29 Cosmetic composition and method for reducing or preventing wrinkling

Publications (3)

Publication Number Publication Date
JP2004508317A JP2004508317A (ja) 2004-03-18
JP2004508317A5 JP2004508317A5 (enExample) 2008-08-14
JP5106739B2 true JP5106739B2 (ja) 2012-12-26

Family

ID=22801588

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002524467A Expired - Fee Related JP5106739B2 (ja) 2000-06-29 2001-06-29 化粧品組成物および方法

Country Status (6)

Country Link
US (1) US6713074B2 (enExample)
EP (1) EP1359897A2 (enExample)
JP (1) JP5106739B2 (enExample)
AU (2) AU7311501A (enExample)
CA (1) CA2414247C (enExample)
WO (1) WO2002019982A2 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030083321A1 (en) * 2001-09-25 2003-05-01 Lerner David S. Composition and method for minimizing or avoiding adverse effects of vesicants
US20080139512A1 (en) * 2002-09-25 2008-06-12 Quick-Med Technologies, Inc. Method for minimizing or avoiding adverse effects of vesicants
US7060304B2 (en) * 2003-04-16 2006-06-13 Access Business Group International Llc Skin whitening compositions containing black cohosh extract
US6994874B2 (en) * 2003-04-16 2006-02-07 Access Business Group International, Llc Skin whitening compositions containing asparagus extract
CA2526222A1 (en) * 2003-05-16 2004-12-02 Arriva Pharmaceuticals, Inc. Treatment of respiratory disease associated with matrix metalloprotease inhibitors
FR2859908A1 (fr) * 2003-09-24 2005-03-25 Oreal Composition comprenant au moins un inhibiteur de metalloproteinase et au moins un agent myorelaxant ou relaxant
JP4803698B2 (ja) * 2004-11-02 2011-10-26 丸善製薬株式会社 抗老化剤、エストロゲン様作用剤、抗男性ホルモン剤、育毛剤、テストステロン５α−レダクターゼ阻害剤、皮膚化粧料及び頭髪化粧料
BRPI0615588A2 (pt) * 2005-08-31 2011-05-24 Serentis Ltd uso de um inibidor de aureolisina para o tratamento de condições inflamatórias da pele caracterizadas por colonização com staphylococcus aureus
US20070142905A1 (en) * 2005-12-16 2007-06-21 Medtronic Vascular, Inc. Medical devices to treat or inhibit restenosis
JP5661994B2 (ja) * 2008-01-04 2015-01-28 クラシエ製薬株式会社 抗ストレス・疲労防止、肌のキメ改善又はシワ改善・防止効果を有する組成物又は内服剤
US20090299466A1 (en) * 2008-06-02 2009-12-03 Medtronic Vascular, Inc. Local Delivery of Matrix Metalloproteinase Inhibitors
US8435541B2 (en) 2010-09-02 2013-05-07 Bath & Body Works Brand Management, Inc. Topical compositions for inhibiting matrix metalloproteases and providing antioxidative activities
GB201110777D0 (en) 2011-06-24 2011-08-10 Aqua Bio Technology Asa Methods and uses
EP3973967A1 (en) 2012-12-21 2022-03-30 Astellas Institute for Regenerative Medicine Methods for production of platelets from pluripotent stem cells and compositions thereof
TWI480057B (zh) * 2013-07-08 2015-04-11 Univ China Medical 咖啡酸醯胺衍生物之應用
US10166412B2 (en) 2014-12-30 2019-01-01 Conopco, Inc. Skin lightening composition comprising 4-hexylresorcinol and ilomastat
CA2971907C (en) * 2014-12-30 2023-08-15 Unilever Plc A skin lightening composition comprising niacinamide and ilomastat
KR102124065B1 (ko) * 2018-08-17 2020-06-17 서울대학교산학협력단 식물 추출물을 함유하는 피부 주름 개선용 조성물
CN114516917B (zh) * 2020-11-20 2022-11-18 广东东阳光药业有限公司 人源化抗TrkA的抗体及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5892112A (en) 1990-11-21 1999-04-06 Glycomed Incorporated Process for preparing synthetic matrix metalloprotease inhibitors
US5268384A (en) 1990-11-21 1993-12-07 Galardy Richard E Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors
FR2717389B1 (fr) * 1994-03-18 1996-06-07 Lvmh Rech Utilisation du ginsénoside Ro ou d'un extrait végétal en contenant pour stimuler la synthèse du collagène.
US5837224A (en) * 1996-01-19 1998-11-17 The Regents Of The University Of Michigan Method of inhibiting photoaging of skin
US5665367A (en) * 1996-09-27 1997-09-09 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin care compositions containing naringenin and/or quercetin and a retinoid
US6338855B1 (en) * 1996-10-25 2002-01-15 The Procter & Gamble Company Cleansing articles for skin and/or hair which also deposit skin care actives
TWI234467B (en) 1997-06-04 2005-06-21 Univ Michigan Composition for inhibiting photoaging of skin
US5885596A (en) 1997-07-23 1999-03-23 Bristol-Myers Squibb Company Methods and compositions for fine lines and/or wrinkles
US6270780B1 (en) * 1997-07-25 2001-08-07 Chesebrough-Pond's Usa Co., Division Of Conopco Cosmetic compositions containing resveratrol
US6030620A (en) * 1997-07-25 2000-02-29 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin care compositions containing an organic extract of chick pea
DE19812204A1 (de) * 1998-03-19 1999-11-04 Plantamed Arzneimittel Gmbh Verwendung von Extrakten aus Cimicifuga racemosa und Belamcanda sinensis als estrogenartiges organselektives Arzneimittel ohne uterotrope Wirkung
FR2782919B1 (fr) * 1998-09-04 2001-05-25 Roc Sa Composition contre le vieillissement et son utilisation
JP2002533404A (ja) 1998-12-23 2002-10-08 ジー・ディー・サール・アンド・カンパニー 新生物形成の治療における組合わせ療法としてインテグリン拮抗剤及び放射線治療を使用する方法
US6139828A (en) 1999-06-02 2000-10-31 Hair Associates, Llc Hair care formulations
US6358517B1 (en) * 1999-10-22 2002-03-19 Unilever Home & Personal Care Usa, Division Of Conopco Cosmetic compositions containing resveratrol and retinoids
WO2001043711A1 (en) * 1999-12-14 2001-06-21 Unilever Plc Cosmetic skin conditioning compositions containing red yeast rice extract
US20020010162A1 (en) * 2000-03-02 2002-01-24 Raul Fleischmajer Treatment of psoriasis with matrix metalloproteinase inhibitors

Also Published As

Publication number Publication date
WO2002019982A3 (en) 2003-07-24
AU2001273115C1 (en) 2009-03-26
US6713074B2 (en) 2004-03-30
CA2414247A1 (en) 2002-03-14
CA2414247C (en) 2012-11-27
EP1359897A2 (en) 2003-11-12
JP2004508317A (ja) 2004-03-18
AU7311501A (en) 2002-03-22
AU2001273115B2 (en) 2005-06-16
WO2002019982A2 (en) 2002-03-14
US20020054922A1 (en) 2002-05-09

Similar Documents

Publication Publication Date Title
JP5106739B2 (ja) 化粧品組成物および方法
US5817666A (en) Dermatological preparation and method for treating actinic keratoses using 5-FU
AU2001273115A1 (en) Cosmetic composition and method
JP2020529980A (ja) 皮膚の弛緩と身体の輪郭を改善するための組成物および方法
JP2004508317A5 (enExample)
JP2011088930A (ja) 二酸化炭素経皮・経粘膜吸収用組成物
JPH04500824A (ja) 光老化の作用を回復させるための皮膚の治療方法
KR20210065968A (ko) 심미적 피부 상태를 치료하기 위한 철 킬레이팅 화합물
CN103494737A (zh) 一种以姜花作为抗衰老护肤因子的化妆品制剂及制备方法
JP2013163681A (ja) 二酸化炭素経皮・経粘膜吸収用組成物
US20040185127A1 (en) Cosmetic composition and method
WO2002058640A1 (en) Topical therapeutic skin care system
JP2009001575A (ja) オゾン溶存グリセリン溶液を含む化粧料、医薬部外品、医薬（医薬品）等の外用剤
JP5164438B2 (ja) 二酸化炭素経皮・経粘膜吸収用組成物
JP2007332078A (ja) オゾン溶存グリセリン溶液を含む化粧料、医薬部外品、医薬（医薬品）等の外用剤
KR20110138709A (ko) 5-아미노레불린산 또는 이의 에스테르를 포함하는 여드름 개선용 조성물
JP2001322990A (ja) 活性酸素消去剤及びそれを含有する活性酸素消去用の組成物
JP2004010598A (ja) 皮膚外用剤
JP2013177460A (ja) 二酸化炭素経皮・経粘膜吸収用組成物
JP2826142B2 (ja) フケ抑制剤組成物
KR102811862B1 (ko) 트로폴론을 포함하는 광반응성 피부 탄력 증진 및/또는 주름 개선용 조성물
JPH0597708A (ja) 歯周病治療剤
US20050096383A1 (en) Method and composition for oral cavity hygiene
JPH0769851A (ja) 口腔用組成物
Steinsapir The chemical peel

Legal Events

Date Code Title Description
RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20080428

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20080612

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20080612

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080630

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080630

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20110125

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110412

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110711

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20110711

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120501

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120731

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120911

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20121003

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20151012

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees